It takes up to ten years to develop a drug and requires investments in the billions to improve existing processes and to develop new products and processes; this is the challenge we must rise up to. The industrial production of chemical, pharmaceutical and biotechnological products places high demands on the process technology used. Here, in particular, on mechanical separation technology. This is because the efficiency of the separating process is increasingly impacting the quality of the end product as well as the economy and environmental-compatibility.
The centrifuges and process lines provided by this business line have a proven track record in the processes of clarification, separation, classification, concentration and fractionation.
The broad application spectrum includes human blood fractionation, the recovery of plant extracts for medication and the recovery of insulin. GEA Westfalia Separator has also made possible significant progress in the separation of microorganisms and their fragments, for example, in the production of vaccines, interferon, antibiotics and enzymes.
In the recovery of superfine particles down to the nano range the centrifuges assure all specified quality grades by way of an extremely precise classification cut. They provide maximum protection and safety where concentrated acids and explosive materials are processed, for instance in the chemical industry.
The separating systems and process lines from GEA Westfalia Separator set international standards in all their fields of performance in terms of constant quality, safety and hygiene that meets CIP and SIP requirements. They are also distinguished by high availability and economic operation.